Orange Book product · Generic (ANDA)
AMOXICILLIN AND CLAVULANATE POTASSIUM
AMOXICILLIN; CLAVULANATE POTASSIUM
At a glance
Nov 29, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 29, 2023
2 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
AMOXICILLIN; CLAVULANATE POTASSIUM
Strength
250MG/5ML;EQ 62.5MG BASE/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
AB
Application
ANDA 210374
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMOXICILLIN; CLAVULANATE POTASSIUM
- 2002AUGMENTIN XRBrand (NDA)
NDA 050785 · US ANTIBIOTICS
- 2001AUGMENTIN ES-600Brand (NDA)
NDA 050755 · US ANTIBIOTICS
- 1996AUGMENTIN '200'Brand (NDA)
NDA 050725 · US ANTIBIOTICS
- 1996AUGMENTIN '200'Brand (NDA)
NDA 050726 · US ANTIBIOTICS
- 1996AUGMENTIN '875'Brand (NDA)
NDA 050720 · US ANTIBIOTICS
- 1985AUGMENTIN '125'Brand (NDA)
NDA 050597 · US ANTIBIOTICS
- 1984AUGMENTIN '125'Brand (NDA)
NDA 050575 · US ANTIBIOTICS
- 1984AUGMENTIN '250'Brand (NDA)
NDA 050564 · US ANTIBIOTICS
- 2023AMOXICILLIN AND CLAVULANATE POTASSIUMGeneric (ANDA)
ANDA 210416 · DEVA HOLDING AS
- 2023AMOXICILLIN AND CLAVULANATE POTASSIUMGeneric (ANDA)
ANDA 217805 · MICRO LABS
- 2023AMOXICILLIN AND CLAVULANATE POTASSIUMGeneric (ANDA)
ANDA 209992 · DEVA HOLDING AS
- 2023AMOXICILLIN AND CLAVULANATE POTASSIUMGeneric (ANDA)
ANDA 209991 · DEVA HOLDING AS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
